Loading clinical trials...
Loading clinical trials...
A 12-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of HP-5000 Topical System (Patch) in Subjects With Osteoarthritis Pain of the Knee
Conditions
Interventions
Diclofenac sodium active topical patch
Placebo patch
Locations
10
United States
Applied Research Center of Arkansas
Little Rock, Arkansas, United States
Clinical Research of West Florida,Inc.
Clearwater, Florida, United States
Universal Axon Clinical Research, LLC
Doral, Florida, United States
The Arthritis and Diabetes Clinic, Inc.
Monroe, Louisiana, United States
Noven Pharmaceuticals, Inc.
Jersey City, New Jersey, United States
Velocity Clinical Research
Cincinnati, Ohio, United States
Start Date
December 29, 2020
Primary Completion Date
July 18, 2022
Completion Date
July 25, 2022
Last Updated
September 4, 2025
Lead Sponsor
Noven Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions